Perceived versus real risks of handling gene transfer agents in the pharmacy environment-Reference-Cited by-同舟云学术

Perceived versus real risks of handling gene transfer agents in the pharmacy environment

Published:2010-05-15 Issue:10 Volume:67 Page:838-848
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Ellison Sharon L.¹,Hunt Debra L.²

Affiliation:

1. Institutional Review Board, Duke University Health System (DUHS), Durham, NC

2. Duke University, Durham, and Director, Biological Safety, Occupational and Environmental Safety Office, DUHS

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/67/10/838/28344126/ajhp0838.pdf

Reference28 articles.

1. Gene therapy: medicine for the future;Green;Am J Health-Syst Pharm,1992

2. National Institutes of Health, Office of Biotechnology Activities. NIH guidelines for research involving recombinant DNA molecules. http://oba.od.nih.gov/rdna/nih_guidelines_oba.html (accessed 2009 Aug 21).

3. Safety issues related to retroviral- mediated gene transfer in humans;Cornetta;Hum Gene Ther,1991

4. Gene therapy on trial;Marshall;Science,2000

5. Researchers and regulators reflect on first gene therapy death;Hollon;Nat Med.,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Hospital Pharmacists (EAHP) guidance on the pharmacy handling of in vivo gene therapy medicinal products;European Journal of Hospital Pharmacy;2024-05-31

2. GMO Medicines and hospital pharmacy practice: a review;Journal of Pharmacy Practice and Research;2021-06